Related references
Note: Only part of the references are listed.Efficacy and Safety of Brexpiprazole for the Treatment of Agitation in Alzheimer's Dementia: Two 12-Week, Randomized, Double-Blind, Placebo-Controlled Trials
George T. Grossberg et al.
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2020)
Drug Repositioning for Alzheimer's Disease: Finding Hidden Clues in Old Drugs
Masafumi Ihara et al.
JOURNAL OF ALZHEIMERS DISEASE (2020)
Results dissemination of registered clinical trials across Polish academic institutions: a cross-sectional analysis
Karolina Strzebonska et al.
BMJ OPEN (2020)
On-Label or Off-Label? Overcoming Regulatory and Financial Barriers to Bring Repurposed Medicines to Cancer Patients
Ciska Verbaanderd et al.
FRONTIERS IN PHARMACOLOGY (2020)
Harnessing endophenotypes and network medicine for Alzheimer's drug repurposing
Jiansong Fang et al.
MEDICINAL RESEARCH REVIEWS (2020)
Quality, scope and reporting standards of randomised controlled trials in Irish Health Research: an observational study
Barbara Clyne et al.
TRIALS (2020)
Type 3 diabetes (Alzheimer's disease): new insight for promising therapeutic avenues
Mayuren Candasamy et al.
PANMINERVA MEDICA (2020)
Alzheimer's disease drug development pipeline: 2020
Jeffrey Cummings et al.
ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS (2020)
CNS repurposing - Potential new uses for old drugs: Examples of screens for Alzheimer's disease, Parkinson's disease and spasticity
Chris G. Parsons
NEUROPHARMACOLOGY (2019)
Pharmacological Potential of Cilostazol for Alzheimer's Disease
Kenjiro Ono et al.
FRONTIERS IN PHARMACOLOGY (2019)
Extracellular Vesicle Biomarkers Track Cognitive Changes Following Intranasal Insulin in Alzheimer's Disease
Maja Mustapic et al.
JOURNAL OF ALZHEIMERS DISEASE (2019)
Insights into Computational Drug Repurposing for Neurodegenerative Disease
Manish D. Paranjpe et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2019)
An analysis of deficiencies in the data of interventional drug trials registered with Clinical Trials Registry - India
Mounika Pillamarapu et al.
TRIALS (2019)
Neuroinflammation and the Gut Microbiota: Possible Alternative Therapeutic Targets to Counteract Alzheimer's Disease?
Milica Cerovic et al.
FRONTIERS IN AGING NEUROSCIENCE (2019)
Alzheimer's disease drug development pipeline: 2019
Jeffrey Cummings et al.
ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS (2019)
Plasma exchange for Alzheimer's disease Management by Albumin Replacement (AMBAR) trial: Study design and progress
Merce Boada et al.
ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS (2019)
Metabolic Dysfunction in Alzheimer's Disease: From Basic Neurobiology to Clinical Approaches
Julia R. Clarke et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
The Coming of Age of the Angiotensin Hypothesis in Alzheimer's Disease: Progress Toward Disease Prevention and Treatment?
Patrick Gavin Kehoe
JOURNAL OF ALZHEIMERS DISEASE (2018)
Prevalence of clinical trial status discrepancies: A cross-sectional study of 10,492 trials registered on both ClinicalTrials.gov and the European Union Clinical Trials Register
Jessica Fleminger et al.
PLOS ONE (2018)
An audit to evaluate an institute's lead researchers' knowledge of trial registries and to investigate adherence to data transparency issues in an Italian research institute registry
Chiara Pandolfini et al.
TRIALS (2018)
Nilvadipine in mild to moderate Alzheimer disease: A randomised controlled trial
Brian Lawlor et al.
PLOS MEDICINE (2018)
Pimavanserin: Potential Treatment For Dementia-Related Psychosis
J. Cummings et al.
JPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASE (2018)
IVIG treatment of mild cognitive impairment due to Alzheimer's disease: a randomised double-blinded exploratory study of the effect on brain atrophy, cognition and conversion to dementia
Shawn Kile et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2017)
Do Cancer Drugs Counteract Neurodegeneration? Repurposing for Alzheimer's Disease
Fiammetta Monacelli et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Clinical trial transparency: a reassessment of industry compliance with clinical trial registration and reporting requirements in the United States
Scott M. Lassman et al.
BMJ OPEN (2017)
Lorazepam Challenge for Individuals at Varying Genetic Risk for Alzheimer Disease
Cynthia M. Stonnington et al.
ALZHEIMER DISEASE & ASSOCIATED DISORDERS (2017)
Repurposed Drugs as Potential Therapeutic Candidates for the Management of Alzheimer's Disease
Muhammad Shoaib et al.
CURRENT DRUG METABOLISM (2017)
In silico repurposing of antipsychotic drugs for Alzheimer's disease
Shivani Kumar et al.
BMC NEUROSCIENCE (2017)
Effects of the Insulin Sensitizer Metformin in Alzheimer Disease: Pilot Data From a Randomized Placebo-controlled Crossover Study
Aaron M. Koenig et al.
ALZHEIMER DISEASE & ASSOCIATED DISORDERS (2017)
Bioinformatics methods in drug repurposing for Alzheimer's disease
John C. Siavelis et al.
BRIEFINGS IN BIOINFORMATICS (2016)
Neuroinflammation in Alzheimer's disease: Current evidence and future directions
Valeria Calsolaro et al.
ALZHEIMERS & DEMENTIA (2016)
Drug Repositioning for Alzheimer's Disease Based on Systematic 'omics' Data Mining
Ming Zhang et al.
PLOS ONE (2016)
Post-mortem assessment of hypoperfusion of cerebral cortex in Alzheimer's disease and vascular dementia
Taya Thomas et al.
BRAIN (2015)
Medical genetics-based drug repurposing for Alzheimer's disease
Xiu-Zhen Zhang et al.
BRAIN RESEARCH BULLETIN (2015)
Tyrosine Kinase Inhibitors as a New Therapy for Ischemic Stroke and other Neurologic Diseases: Is there any Hope for a Better Outcome?
Iwona Gagalo et al.
CURRENT NEUROPHARMACOLOGY (2015)
Compliance with Results Reporting at ClinicalTrials.gov
Monique L. Anderson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Novel insight into drug repositioning: Methylthiouracil as a case in point
Moon-Chang Baek et al.
PHARMACOLOGICAL RESEARCH (2015)
Repurpose terbutaline sulfate for amyotrophic lateral sclerosis using electronic medical records
Hyojung Paik et al.
SCIENTIFIC REPORTS (2015)
Alzheimer's disease
Colin L. Masters et al.
NATURE REVIEWS DISEASE PRIMERS (2015)
Agitation in cognitive disorders: International Psychogeriatric Association provisional consensus clinical and research definition
Jeffrey Cummings et al.
INTERNATIONAL PSYCHOGERIATRICS (2015)
Economic analysis of opportunities to accelerate Alzheimer's disease research and development
Troy J. Scott et al.
ANNALS REPORTS (2014)
Pimavanserin for patients with Parkinson's disease psychosis: a randomised, placebo-controlled phase 3 trial
Jeffrey Cummings et al.
LANCET (2014)
A Review: Treatment of Alzheimer's Disease Discovered in Repurposed Agents
Brian S. Appleby et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2013)
Effects of cilostazol on cognition and regional cerebral blood flow in patients with Alzheimer's disease and cerebrovascular disease: A pilot study
Hirofumi Sakurai et al.
GERIATRICS & GERONTOLOGY INTERNATIONAL (2013)
Drug Repositioning: An Opportunity to Develop Novel Treatments for Alzheimer's Disease
Anne Corbett et al.
PHARMACEUTICALS (2013)
Repurposing with a Difference
Mark S. Boguski et al.
SCIENCE (2009)
Protective effects of cilostazol against transient focal cerebral ischemia and chronic cerebral hypoperfusion injury
Jeong Hyun Lee et al.
CNS NEUROSCIENCE & THERAPEUTICS (2008)
Forecasting the global burden of Alzheimer's disease
Ron Brookmeyer et al.
ALZHEIMERS & DEMENTIA (2007)
Share Paper
